Today: 28 June 2026
CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge
4 January 2026
2 mins read

CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge

NEW YORK, January 3, 2026, 20:10 ET — Market closed

  • CoreWeave disclosed an amendment to its DDTL 3.0 credit agreement, easing minimum liquidity and delaying some covenant tests.
  • Shares last closed up 10.77% at $79.32 on Friday, after trading between $73.16 and $81.17.
  • Next catalysts include the amendment exhibit in the coming Form 10-K and an estimated Feb. 9 earnings window on Nasdaq’s calendar.

CoreWeave, Inc. said it amended a credit agreement tied to its DDTL 3.0 facility, a regulatory filing showed.

Shares of the AI cloud provider closed Friday up 10.77% at $79.32, data showed.

The amendment lands as investors weigh how quickly debt-heavy AI infrastructure companies can keep adding capacity without tripping lender safeguards. Covenants — rules inside loan documents that require cash levels or financial ratios — can force a borrower to raise funding or curb spending if it falls short.

DDTL stands for delayed-draw term loan, which lets a borrower take down funding over time rather than all at once. CoreWeave said the change was meant to align the facility with the timing of deliveries discussed on its earnings call for the quarter ended Sept. 30, 2025.

The amendment, signed on Dec. 31, changes the DDTL 3.0 credit agreement originally dated July 28, 2025, with MUFG Bank as administrative agent and U.S. Bank among the counterparties, the filing said. It cuts the minimum liquidity amount (cash and other readily available funds) for monthly payment dates ending on and after March 1, 2026 and prior to May 1, 2026 to $100 million, and postpones the first tests of the debt service coverage ratio — a cashflow-to-debt-payment metric — until Oct. 31, 2027 and the contract realization ratio until Feb. 28, 2026. CoreWeave said it can use an unlimited number of “equity cures” — equity injections to remedy a covenant breach — until Oct. 28, 2026, subject to limits after that. SEC

Broader U.S. equities were mixed on Friday, with the Nasdaq easing while the S&P 500 and Dow finished higher as traders watched bond yields and the Federal Reserve outlook. CoreWeave outperformed that tape.

CoreWeave has leaned on capital markets to fund rapid buildouts of AI data-center capacity. In December it priced an upsized $2.25 billion offering of 1.75% convertible senior notes due 2031, according to a company statement. Convertible notes are debt that can convert into shares, potentially diluting existing holders.

Debt has become a flashpoint for skeptics. “They have to keep borrowing more and more because they spend more money than they can get,” D.A. Davidson analyst Gil Luria told The Verge. The Verge

CoreWeave trimmed its annual revenue forecast in November after data center partner delays, Reuters reported, sharpening investor focus on delivery schedules and financing needs.

Before the next session, investors will look for the full amendment text in CoreWeave’s annual report, which the company said would include it as an exhibit. Nasdaq’s earnings calendar listed Feb. 9 as an estimated report date, though companies often confirm dates closer to the release.

Technicians will watch whether the stock can hold Friday’s breakout above the prior close around $71.61. The shares traded between $73.16 and $81.17 and changed hands in a volume of about 30 million shares.

Macro data could set the tone for high-growth AI names next week, with investors watching the U.S. jobs report due on Jan. 9 for clues on rates and risk appetite, a Reuters column said.

For CoreWeave, the immediate question is whether covenant breathing room and delivery timing translate into steadier cash metrics once markets reopen. Any further funding moves or customer capacity updates are likely to keep the stock volatile.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • SITC Leaders Ring NYSE Opening Bell to Mark Biotech Strategic Meeting
    June 27, 2026, 7:16 PM EDT. Leaders from the Society for Immunotherapy of Cancer (SITC), James Gulley and Zhen Su, rang the New York Stock Exchange (NYSE) opening bell. The event highlighted advances in immuno-oncology, a treatment that uses the immune system to fight cancer. This ceremony also marked the annual SITC Biotech Strategic Meeting at the NYSE, underscoring the biotech sector's role in innovation and market activity.

Latest articles

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

28 June 2026
Hecla Mining surged 5.3 times its average trading volume Friday as index rebalancing drove 112.44 million shares traded, but the stock’s 2.6% weekly drop still beat silver and peer ETFs, signaling company-specific strength; investors now watch if Hecla can hold above $15.54 without rebalancing flows as macro risks loom.
Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Previous Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

PBF Energy stock in focus after U.S. strikes Venezuela; Martinez restart, earnings date ahead
Next Story

PBF Energy stock in focus after U.S. strikes Venezuela; Martinez restart, earnings date ahead

Go toTop